Mga Batayang Estadistika
| LEI | B8PTJH2P0AXSWSMP2136 |
| CIK | 861878 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Stericycle, Inc. 5.25% Series A Preferred
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-37556 Stericycle, Inc. (Exact name of registrant as specified in its ch |
|
| November 13, 2024 |
SC 13G 1 bc88220srcl-13g.htm STERICYCLE, INC. UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Stericycle, Inc. (Name of Issuer) Common (Title of Class of Securities) 858912108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| November 12, 2024 |
SRCL / Stericycle, Inc. / Capital Research Global Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Stericycle, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 8, 2024 |
SC 13G/A 1 ccpsc13ga2stericycle110824.htm SC 13G/A#2 FOR CCP AND STERICYCLE, INC. Page 1 of 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* St |
|
| November 8, 2024 |
Exhibit 10.2 Execution Version FIRST SUPPLEMENTAL INDENTURE First Supplemental Indenture (this “Supplemental Indenture”), dated as of November 5, 2024, among Stericycle, Inc., a Delaware corporation (the “Company”), the Guarantor party thereto, and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association, as trustee |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 Stericycle, Inc. |
|
| November 4, 2024 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION STERICYCLE, INC. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF STERICYCLE, INC. FIRST: The name of this corporation is Stericycle, Inc. (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street, County of New Castle, Wilmington, Delaware 19801. The name of the Corporation’s registered agent at suc |
|
| November 4, 2024 |
Registration No. 333-102144 No. 333-72870 No. 333-68622 No. 333-67582 No. 333-60591 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-102144 POST-EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-72870 POST-EFFECTIVE AMENDMENT NO. 5 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333- |
|
| November 4, 2024 |
Registration No. 333-102144 No. 333-72870 No. 333-68622 No. 333-67582 No. 333-60591 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-102144 POST-EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-72870 POST-EFFECTIVE AMENDMENT NO. 5 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333- |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| November 4, 2024 |
STERICYCLE, INC. (Adopted as of November 4, 2024) ARTICLE I MEETINGS OF STOCKHOLDERS Exhibit 3.2 STERICYCLE, INC. BYLAWS (Adopted as of November 4, 2024) ARTICLE I MEETINGS OF STOCKHOLDERS Section 1. Place of Meeting. Meetings of the stockholders of Stericycle, Inc. (the “Corporation”) shall be held at such place either within or without the State of Delaware as the Board of Directors may determine. Section 2. Annual and Special Meetings. Annual meetings of stockholders shall be h |
|
| November 4, 2024 |
Registration No. 333-102144 No. 333-72870 No. 333-68622 No. 333-67582 No. 333-60591 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-102144 POST-EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-72870 POST-EFFECTIVE AMENDMENT NO. 5 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333- |
|
| November 4, 2024 |
Registration No. 333-102144 No. 333-72870 No. 333-68622 No. 333-67582 No. 333-60591 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-102144 POST-EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-72870 POST-EFFECTIVE AMENDMENT NO. 5 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333- |
|
| November 4, 2024 |
Registration No. 333-102144 No. 333-72870 No. 333-68622 No. 333-67582 No. 333-60591 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-102144 POST-EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333-72870 POST-EFFECTIVE AMENDMENT NO. 5 TO REGISTRATION STATEMENT ON FORM S-3 NO. 333- |
|
| November 1, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| September 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| September 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 25, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-3 |
|
| July 25, 2024 |
Execution Version 1908230902 CANADIAN BENCHMARK REPLACEMENT CONFORMING CHANGES AMENDMENT THIS CANADIAN BENCHMARK REPLACEMENT CONFORMING CHANGES AMENDMENT (this “Agreement”), dated as of June 28, 2024, is entered into by BANK OF AMERICA, N. |
|
| July 10, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| June 21, 2024 |
Exhibit 107 Exhibit 107 Calculation of Filing Fee Tables SCHEDULE 14A (Form Type) STERICYCLE, INC. |
|
| June 21, 2024 |
PREM14A 1 d768297dprem14a.htm PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| June 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
Exhibit 2.1 Execution Version CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THE OMITTED PORTIONS OF THIS DOCUMENT ARE INDICATED BY [***]. AGREEMENT AND PLAN OF MERGER by and among WASTE MANAGEMENT, INC., STAG MERGER SUB INC. and STERICYCLE, INC. Dated as of June 3, 2024 TABLE OF CONTENTS Pag |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| June 3, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE WM to Acquire Stericycle, a Leader in Medical Waste Services, for $7.2 Billion Expands WM’s Comprehensive Environmental Solutions in the Growing Healthcare Market While Advancing WM’s Sustainability Commitments • Provides a complementary business platform in the healthcare market, a sector with attractive near- and long-term growth dynamics • Positions WM to of |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Stericycle, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2024 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 25, 2024 |
Stericycle, Inc. Outside Directors Compensation Policy, as amended, effective September 13, 2023 1 Stericycle, Inc. Outside Directors Compensation Policy (the “Policy”) (Amended September 13, 2023) ANNUAL COMPENSATION Annual Retainer Each Outside Director shall receive an “Annual Retainer” consisting of an Annual Cash Retainer and an Annual Equity Retainer, each as described below. For purposes of the Policy, unless otherwise specified, an equity award for a year shall be an award for the per |
|
| April 25, 2024 |
US.363534882.03 Exhibit 10.3 STERICYCLE, INC. EXECUTIVE SEVERANCE AND CHANGE IN CONTROL PLAN AS AMENDED AND RESTATED EFFECTIVE APRIL 23, 2024 Exhibit 10.3 i TABLE OF CONTENTS Page ARTICLE I Statement of Purpose and Effective Date................................................................ 1 1.01 Purpose............................................................................................ |
|
| April 25, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1- |
|
| April 25, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 25, 2024 |
Stericycle, Inc. Reports Results For The First Quarter 2024 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media Relations 847-964-2288 Stericycle, Inc. Reports Results For The First Quarter 2024 BANNOCKBURN, Ill., April 25, 2024 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2024. Revenues for the first quarter were $664.9 million, a decrease of 2.8% compa |
|
| April 5, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| April 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| February 28, 2024 |
Exhibit 21 Subsidiaries of Registrant U.S. Subsidiaries * Stericycle International, LLC (Delaware) Stericycle Management, LLC (Delaware) Stericycle of Washington, Inc. (Washington) SteriVentures, LLC (Delaware) Stroud Properties, Inc. (Delaware) Non-US Subsidiaries* Shred-it Insurance Limited (Barbados) Shred-it Belgium (Belgium) Stericycle, ULC (Canada) SRCL Cyprus Ltd. (Cyprus) Shred-it France ( |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2024 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 28, 2024 |
Stericycle, Inc. Reports Results For The Fourth Quarter 2023 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media Relations 847-964-2288 Stericycle, Inc. Reports Results For The Fourth Quarter 2023 BANNOCKBURN, Ill., February 28, 2024 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2023. Revenues for the fourth quarter were $652.0 million, a decrease of 2 |
|
| February 28, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle |
|
| February 14, 2024 |
SRCL / Stericycle, Inc. / ALLIANCEBERNSTEIN L.P. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Stericycle Inc (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 13, 2024 |
SRCL / Stericycle, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01996-stericycleinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Stericycle Inc Title of Class of Securities: Common Stock CUSIP Number: 858912108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the |
|
| February 13, 2024 |
SC 13G 1 bc87056srcl-13g.htm STERICYCLE, INC. UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Stericycle, Inc. (Name of Issuer) Common (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 12, 2024 |
SC 13G/A 1 stericycle13ga1-021414.htm CCP SC 13GA1 - STERICYCLE INC Page 1 of 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Stericycle Inc. |
|
| February 9, 2024 |
SRCL / Stericycle, Inc. / Capital Research Global Investors - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Stericycle, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2024 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 2, 2023 |
Stericycle, Inc. Annual Incentive Plan, as amended, effective January 1, 2024 Exhibit 10.1 Stericycle, Inc. Annual Incentive Plan Article 1. Purpose The purpose of this Plan is to encourage key employees of Stericycle, Inc. (“Stericycle” or the “Company”), or any participating Affiliated Company to which the Plan is extended, to focus on the achievement of the Company’s objectives and to maximize the retention of such employees by offering discretionary rewards for substant |
|
| November 2, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 2, 2023 |
EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media Relations 847-964-2288 Stericycle, Inc. Reports Results For the Third Quarter 2023 Company successfully deploys the ERP to U.S. Regulated Waste and Compliance Services BANNOCKBURN, Ill., November 2, 2023 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the third quarter ended Septe |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 27, 2023 |
EXECUTION VERSION 1741738664 STERICYCLE, INC. SECOND AMENDMENT This SECOND AMENDMENT, dated as of June 15, 2023 (this “Amendment”), is entered into by and among STERICYCLE, INC., a Delaware corporation (the “Company”), the Subsidiaries of the Company signatory hereto (collectively, together with the Company, the “Loan Parties” and, each a “Loan Party”), the Lenders (as defined below) signatory her |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| July 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-3 |
|
| July 27, 2023 |
Stericycle, Inc. Reports Results For the Second Quarter 2023 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media Relations 847-964-2288 Stericycle, Inc. Reports Results For the Second Quarter 2023 BANNOCKBURN, Ill., July 27, 2023 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2023. Revenues for the second quarter were $669.5 million, a decrease of 1.5% comp |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2023 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 18, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 27, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 27, 2023 |
Stericycle, Inc. Reports Results For the First Quarter 2023 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media Relations 847-964-2288 Stericycle, Inc. Reports Results For the First Quarter 2023 BANNOCKBURN, Ill., April 27, 2023 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2023. Revenues for the first quarter were $684.3 million, an increase of 3.0% comp |
|
| April 27, 2023 |
Form of Performance Stock Unit Award Agreement under the 2021 Long-Term Incentive Plan Exhibit 10.2 STERICYCLE, INC. 2021 LONG-TERM INCENTIVE PLAN Performance Stock Unit Award Agreement Stericycle, Inc. (the “Company”), pursuant to its 2021 Long-Term Incentive Plan (the “Plan”), hereby grants an award of Performance Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Performance Stock Unit Award Agreement (the “Agreement”), c |
|
| April 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1- |
|
| April 27, 2023 |
Form of Restricted Stock Unit Award Agreement under the 2021 Long-Term Incentive Plan Exhibit 10.1 STERICYCLE, INC. 2021 LONG-TERM INCENTIVE PLAN Restricted Stock Unit Award Agreement Stericycle, Inc. (the “Company”), pursuant to its 2021 Long-Term Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreement (the “Agreement”), cons |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| March 31, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| February 23, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2023 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 23, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle |
|
| February 23, 2023 |
Exhibit 21 Subsidiaries of Registrant U.S. Subsidiaries * Stericycle International, LLC (Delaware) Stericycle Management, LLC (Delaware) Stericycle of Washington, Inc. (Washington) SteriVentures, LLC (Delaware) Stroud Properties, Inc. (Delaware) Non-US Subsidiaries* Stericycle Australia Pty Ltd (Australia) Shred-it Australia Pty Ltd (Australia) Shred-it Insurance Limited (Barbados) Metalchem/DRS ( |
|
| February 23, 2023 |
Stericycle, Inc. Reports Results For the Fourth Quarter 2022 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media Relations 847-964-2288 Stericycle, Inc. Reports Results For the Fourth Quarter 2022 BANNOCKBURN, Ill., February 23, 2023 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2022. Revenues for the fourth quarter were $670.4 million, an increase of |
|
| February 14, 2023 |
EX-99.1 2 stericycleex991021423.htm JOINT FILING AGREEMENT EXHIBIT 99.1 Joint Filing Agreement The undersigned acknowledge and agree that the Schedule 13G with respect to beneficial ownership by the undersigned of shares of Common Stock, par value $0.01 per share, of Stericycle Inc. filed on or about the date hereof is being filed on behalf of each of the undersigned in accordance with Rule 13d-1( |
|
| February 14, 2023 |
SRCL / Stericycle Inc / ALLIANCEBERNSTEIN L.P. - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Stericycle Inc (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi |
|
| February 14, 2023 |
SRCL / Stericycle Inc / Clarkston Capital Partners, LLC - CCP/STERICYCLE SC 13G Passive Investment SC 13G 1 stericyclesc13g021423.htm CCP/STERICYCLE SC 13G Page 1 of 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Stericycle Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the |
|
| February 9, 2023 |
SRCL / Stericycle Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01965-stericycleinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Stericycle Inc. Title of Class of Securities: Common Stock CUSIP Number: 858912108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the |
|
| February 8, 2023 |
SRCL / Stericycle Inc / Black Creek Investment Management Inc. Passive Investment SC 13G 1 srcl85292.htm UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Stericycle, Inc. (Name of Issuer) Common (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 15, 2022 |
Stericycle Appoints Naren K. Gursahaney to Board of Directors, Continuing Board Evolution EXHIBIT 99.1 Stericycle Appoints Naren K. Gursahaney to Board of Directors, Continuing Board Evolution BANNOCKBURN, Ill. — Dec. 14, 2022 — Stericycle, Inc. (Nasdaq: SRCL), a leading provider of regulated medical waste management and secure information destruction solutions, announced today the appointment of Naren K. Gursahaney to the Stericycle Board of Directors, effective January 1, 2023. “Foll |
|
| December 15, 2022 |
scl202212148-kex32 Amended and Restated Bylaws of Stericycle, Inc. (as amended through December 13, 2022) ARTICLE 1. OFFICES 1.1 Registered Office The Corporation’s registered office in the State of Delaware shall be located at 1209 Orange Street, Wilmington, Delaware 19801 (New Castle County), and its registered agent shall be The Corporation Trust Company. The Corporation’s registered office and |
|
| December 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2022 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 3, 2022 |
Stericycle, Inc. Reports Results For the Third Quarter 2022 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media 847-964-2288 Stericycle, Inc. Reports Results For the Third Quarter 2022 BANNOCKBURN, Ill., November 3, 2022 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the third quarter ended September 30, 2022. Revenues for the third quarter were $690.3 million, an increase of 6.4% compared |
|
| November 3, 2022 |
Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 2, 2022 |
CORRESP 1 filename1.htm November 2, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Energy & Transportation 100 F Street, N.E. Washington, D.C. 20549 Attention: Anuja A. Majmudar Karina Dorin Re: SEC Comment Letter dated October 20, 2022 Stericycle, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Response dated October 3, 2022 File No. 00 |
|
| October 3, 2022 |
CORRESP 1 filename1.htm October 3, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Energy & Transportation 100 F Street, N.E. Washington, D.C. 20549 Attention: Anuja A. Majmudar Karina Dorin Re: SEC Comment Letter dated September 12, 2022 Stericycle, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Response dated August 31, 2022 File No. 0 |
|
| September 16, 2022 |
September 16, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Energy & Transportation 100 F Street, N.E. Washington, D.C. 20549 Attention: Anuja A. Majmudar Karina Dorin Re: SEC Comment Letter dated September 12, 2022 Stericycle, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Response dated August 31, 2022 File No. 001-37556 Dear Mses. M |
|
| August 31, 2022 |
August 31, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Energy & Transportation 100 F Street, N.E. Washington, D.C. 20549 Attention: Anuja A. Majmudar Karina Dorin Re: SEC Comment Letter dated August 4, 2022 Stericycle, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Filed February 24, 2022 File No. 001-37556 Dear Mses. Majmudar and Do |
|
| August 16, 2022 |
CORRESP 1 filename1.htm August 16, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Energy & Transportation 100 F Street, N.E. Washington, D.C. 20549 Attention: Anuja A. Majmudar Karina Dorin Re: SEC Comment Letter dated August 4, 2022 Stericycle, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Filed February 24, 2022 File No. 001-37556 De |
|
| August 5, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2022 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 5, 2022 |
Stericycle, Inc. Reports Results For the Second Quarter 2022 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media 847-964-2288 Stericycle, Inc. Reports Results For the Second Quarter 2022 BANNOCKBURN, Ill., August 5, 2022 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2022. Revenues for the second quarter were $679.8 million, an increase of 1.1% compared to |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-3 |
|
| August 5, 2022 |
Amendment to the Stericycle, Inc. Annual Incentive Plan FIRST AMENDMENT To the STERICYCLE, INC. ANNUAL INCENTIVE PLAN (As in Effect on January 1, 2021) This First Amendment to the Stericycle, Inc. Annual Incentive Plan, as in effect on January 1, 2021 (the ?Plan?) is hereby made effective January 1, 2022 for the purpose of revising the post-death payment rules under the Plan. NOW THEREFORE, the Plan is hereby amended by Stericycle, Inc. as Plan sponsor |
|
| June 1, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2022 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 28, 2022 |
SECURITIES & EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NOTICE OF EXEMPT SOLICITATION (VOLUNTARY SUBMISSION) NAME OF REGISTRANT: Stericycle, Inc. NAME OF PERSON RELYING ON EXEMPTION: International Brotherhood of Teamsters ADDRESS OF PERSON RELYING ON EXEMPTION: 25 Louisiana Avenue, N.W. Washington, D.C. 20001 Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securi |
|
| April 28, 2022 |
Exhibit 10.2 STERICYCLE, INC. 2021 LONG-TERM INCENTIVE PLAN Restricted Stock Unit Award Agreement Stericycle, Inc. (the ?Company?), pursuant to its 2021 Long-Term Incentive Plan (the ?Plan?), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreement (the ?Agreement?), cons |
|
| April 28, 2022 |
Stericycle, Inc. Reports Results For the First Quarter 2022 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Media 847-964-2288 Stericycle, Inc. Reports Results For the First Quarter 2022 BANNOCKBURN, Ill., April 28, 2022 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2022. Revenues for the first quarter were $664.2 million, a decrease of 0.6% compared to $66 |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1- |
|
| April 28, 2022 |
Exhibit 10.3 STERICYCLE, INC. 2021 LONG-TERM INCENTIVE PLAN Performance Stock Unit Award Agreement Stericycle, Inc. (the ?Company?), pursuant to its 2021 Long-Term Incentive Plan (the ?Plan?), hereby grants an award of Performance Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Performance Stock Unit Award Agreement (the ?Agreement?), c |
|
| April 28, 2022 |
EXECUTION VERSION STERICYCLE, INC. FIRST AMENDMENT This FIRST AMENDMENT, dated as of April 26, 2022 (this ?Amendment?), is entered into by and among STERICYCLE, INC., a Delaware corporation (the ?Company?), the Subsidiaries of the Company signatory hereto (collectively, together with the Company, the ?Loan Parties? and, each a ?Loan Party?), the Lenders (as defined below) signatory hereto, and BAN |
|
| April 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 14, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.? ) ? Filed by the Registrant ? ? ? Filed by a Party other than the Registrant Check the appropriate box: ? ? ? Preliminary Proxy Statement ? ? ? Confidential, for Use of the Commission Only (as permitt |
|
| April 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.? ) ? Filed by the Registrant ? ? ? Filed by a Party other than the Registrant Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? |
|
| February 24, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle |
|
| February 24, 2022 |
Exhibit 21 Subsidiaries of Registrant U.S. Subsidiaries * 1 Stericycle Communication Solutions, Inc. (Delaware) 2 Stericycle International, LLC (Delaware) 3 Stericycle Management, LLC (Delaware) 4 Stericycle of Washington, Inc. 5 SteriVentures, LLC 6 Stroud Properties, Inc. 7 The MPB Group, LLC (Delaware) Non-US Subsidiaries* 1 Metalchem/DRS BVBA (Belgium) 2 SRCL Cyprus Ltd (Cyprus) 3 SRCL Ireland |
|
| February 24, 2022 |
Stericycle, Inc. Reports Results For the Fourth Quarter 2021 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Fourth Quarter 2021 BANNOCKBURN, Ill., February 24, 2022 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2021 and also announced a Regulated Waste and Compliance (?RWCS?) acquisition. Revenues for the fourth quarter wer |
|
| February 24, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 14, 2022 |
SRCL / Stericycle Inc / ALLIANCEBERNSTEIN L.P. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Stericycle Inc (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 10, 2022 |
SRCL / Stericycle Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Stericycle Inc. Title of Class of Securities: Common Stock CUSIP Number: 858912108 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru |
|
| November 2, 2021 |
Section 1350 Certification of Chief Executive Officer and Chief Financial Officer Exhibit 32 SECTION 1350 CERTIFICATION In connection with the Quarterly Report of Stericycle, Inc. |
|
| November 2, 2021 |
Stericycle, Inc. Reports Results For the Third Quarter 2021 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Third Quarter 2021 BANNOCKBURN, Ill., November 2, 2021 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the third quarter ended September 30, 2021. Revenues for the third quarter were $648.9 million, an increase of 2.0% compared to $636.4 million in the thir |
|
| November 2, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2021 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File |
|
| October 4, 2021 |
Exhibit 10.1 CUSIP Numbers: Deal: 85915LAQ1 Revolver: 85915LAR9 Term Loan: 85915LAS7 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of September 30, 2021 among STERICYCLE, INC., and CERTAIN SUBSIDIARIES as Borrowers, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender, a Lender and an L/C Issuer, THE OTHER LENDERS PARTY HERETO, JPMORGAN CHASE BANK, N.A., and SUMITOMO MITSUI BANKING C |
|
| August 6, 2021 |
Form of Performance Stock Unit Award Agreement under the 2021 Long-Term Incentive Plan Exhibit 10.4 STERICYCLE, INC. 2021 LONG-TERM INCENTIVE PLAN Performance Stock Unit Award Agreement Stericycle, Inc. (the ?Company?), pursuant to its 2021 Long-Term Incentive Plan (the ?Plan?), hereby grants an award of Performance Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Performance Stock Unit Award Agreement (the ?Agreement?), c |
|
| August 6, 2021 |
Form of Restricted Stock Unit Award Agreement under the 2021 Long-Term Incentive Plan Exhibit 10.3 STERICYCLE, INC. 2021 LONG-TERM INCENTIVE PLAN Restricted Stock Unit Award Agreement Stericycle, Inc. (the ?Company?), pursuant to its 2021 Long-Term Incentive Plan (the ?Plan?), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreement (the ?Agreement?), cons |
|
| August 6, 2021 |
Stericycle, Inc. Reports Results For the Second Quarter 2021 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Second Quarter 2021 BANNOCKBURN, Ill., August 6, 2021 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2021. Revenues for the second quarter were $672.7 million, an increase of 12.5% compared to $598.2 million in the second |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-3 |
|
| August 6, 2021 |
Exhibit 10.2 Director Restricted Stock Unit Award (Stericycle, Inc. 2021 Long-Term Incentive Plan) Stericycle, Inc. (the ?Company?), pursuant to its 2021 Long-Term Incentive Plan (the ?Plan?), hereby grants an award of Restricted Stock Units to you, the Non-Employee Director named below, as a ?Participant? in the Plan. The terms and conditions of this Award are set forth in this Restricted Stock U |
|
| August 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2021 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 28, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2021 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 6, 2021 |
SECURITIES & EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NOTICE OF EXEMPT SOLICITATION (VOLUNTARY SUBMISSION) NAME OF REGISTRANT: Stericycle, Inc. NAME OF PERSON RELYING ON EXEMPTION: International Brotherhood of Teamsters ADDRESS OF PERSON RELYING ON EXEMPTION: 25 Louisiana Avenue, N.W., Washington D.C. 20001 Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securi |
|
| April 29, 2021 |
1 Performance-Based Stock Unit Award (Stericycle, Inc. 2011 Incentive Stock Plan) Participant: Award Grant Date (?Grant Date?): Number of shares subject to this Award: Performance Period: Three fiscal years beginning in the year in which the grant is awarded Performance Year: Each calendar year during the Performance Period THIS PERFORMANCE-BASED STOCK UNIT AGREEMENT (this ?Award Agreement?), date |
|
| April 29, 2021 |
1 Restricted Stock Unit Award (Stericycle, Inc. 2011 Incentive Stock Plan) Participant: %%FIRSTNAME%-% %%LASTNAME%-% Award Grant Date (?Grant Date?): %%OPTIONDATE,'Month DD, YYYY'%-% Number of shares subject to this Award: %%TOTALSHARESGRANTED,'999,999,999'%-% Vesting Schedule Via as Follows: Shares Vesting Date %%SHARESPERIOD1,?9 99,999,999?%-% %%VESTDATEPERI OD1,?Month DD, YYYY?%-% %%decode(SHAR |
|
| April 29, 2021 |
Stericycle, Inc. Reports Results For the First Quarter 2021 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the First Quarter 2021 BANNOCKBURN, Ill., April 29, 2021 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2021. Revenues for the first quarter were $668.0 million, a decrease of 14.9% compared to $785.0 million in the first quar |
|
| April 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2021 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 29, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1- |
|
| April 14, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.? ) ? Filed by the Registrant ? ? ? Filed by a Party other than the Registrant Check the appropriate box: ? ? ? Preliminary Proxy Statement ? ? ? Confidential, for Use of the Commission Only (as permitt |
|
| April 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.? ) ? Filed by the Registrant ? ? ? Filed by a Party other than the Registrant Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? |
|
| February 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2021 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 25, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle |
|
| February 25, 2021 |
Exhibit 21 Subsidiaries of Registrant U.S. Subsidiaries * 1 Stericycle Communication Solutions, Inc. (Delaware) 2 Stericycle International, LLC (Delaware) 3 Stericycle Management, LLC (Delaware) 4 Stericycle of Washington, Inc. 5 SteriVentures, LLC 6 Stroud Properties, Inc. 7 The MPB Group, LLC (Delaware) Non-US Subsidiaries* 1 Metalchem/DRS BVBA (Belgium) 2 SRCL Cyprus Ltd (Cyprus) 3 SRCL Ireland |
|
| February 25, 2021 |
Stericycle, Inc. Reports Results For the Fourth Quarter 2020 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Fourth Quarter 2020 BANNOCKBURN, Ill., February 25, 2021 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2020. Revenues for the fourth quarter were $655.9 million, a decrease of 18.0% compared to $799.9 million in the f |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Stericycle Inc. Title of Class of Securities: Common Stock CUSIP Number: 858912108 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru |
|
| February 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Stericycle Inc (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| December 2, 2020 |
Stericycle Investor Relations 847-607-2012 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle Divests Its Global Product Recall Business BANNOCKBURN, Ill., December 2, 2020 - Stericycle, Inc. (Nasdaq: SRCL) today announced that it has completed the divestiture of its global product recall business (Expert Solutions) to Sedgwick. Stericycle intends to use the net proceeds from the divestiture |
|
| December 2, 2020 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 24, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 24, 2020 |
EX-4.1 2 d16738dex41.htm EX-4.1 Exhibit 4.1 INDENTURE Dated as of November 24, 2020 Between STERICYCLE, INC., THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO And U.S. BANK NATIONAL ASSOCIATION, as Trustee 3.875% SENIOR NOTES DUE 2029 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 26 Section 1.03. [Reserved] |
|
| November 10, 2020 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 10, 2020 |
Stericycle Announces Pricing of $500.0 Million Senior Notes Offering EX-99.1 Exhibit 99.1 Stericycle Announces Pricing of $500.0 Million Senior Notes Offering BANNOCKBURN, IL., November 9, 2020 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) announced today that it has priced an offering of $500.0 million aggregate principal amount of 3.875% senior notes due January 15, 2029 (the “Notes”). The Notes were priced at par and will be senior unsecured |
|
| November 9, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 9, 2020 |
Stericycle Announces Proposed Offering of $400.0 Million Aggregate Principal Amount of Senior Notes EX-99.1 2 d54006dex991.htm EX-99.1 Exhibit 99.1 Stericycle Announces Proposed Offering of $400.0 Million Aggregate Principal Amount of Senior Notes BANNOCKBURN, IL., November 9, 2020 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) announced today that it intends to commence an offering of $400.0 million aggregate principal amount of senior notes due 2029 (the “Notes”), subject to |
|
| November 5, 2020 |
Stericycle, Inc. Reports Results For the Third Quarter 2020 EX-99.1 2 scl-20200930xexx991.htm EX-99.1 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Third Quarter 2020 BANNOCKBURN, Ill., November 5, 2020 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the third quarter ended September 30, 2020. Revenues for the quarter were $636.4 million, a decrease of 23.6% co |
|
| November 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 5, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| September 9, 2020 |
STERICYCLE, INC. 2355 Waukegan Road Bannockburn, IL 60015 (847) 367-5910 September 9, 2020 VIA EDGAR Mr. Brian McAllister and Ms. Myra Moosariparambil Division of Corporation Finance Office of Energy and Transportation U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Stericycle Inc. Form 10-K for the Fiscal Year Ended December 31, 2019 Form 10-Q for the Fiscal |
|
| August 27, 2020 |
STERICYCLE, INC. 2355 Waukegan Road Bannockburn, IL 60015 (847) 367-5910 August 27, 2020 VIA EDGAR Mr. Brian McAllister and Ms. Myra Moosariparambil Division of Corporation Finance Office of Energy & Transportation Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Stericycle, Inc. Form 10-K for the Fiscal Year Ended December 31, 2019 Form 10-Q for the Fiscal Quarter |
|
| August 10, 2020 |
S-8 As filed with the Securities and Exchange Commission on August 10, 2020 Registration No. |
|
| August 6, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle, I |
|
| August 6, 2020 |
Stericycle, Inc. Reports Results For the Second Quarter 2020 EX-99.1 2 srcl-ex9916.htm EX-99.1 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Second Quarter 2020 BANNOCKBURN, Ill., August 6, 2020 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2020. Revenues for the quarter were $598.2 million, a decrease of 29.3% compared to $84 |
|
| July 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (C |
|
| July 8, 2020 |
Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is entered into by and between Stericycle, Inc. (the “Company” or “Stericycle”) and David Stahl (“Stahl”). WHEREAS, Stahl previously was selected to participate in the Company’s Executive Severance and Change in Control Plan with an effective date of January 1, 2020 (the “Severance Pla |
|
| June 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| June 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 28, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 7, 2020 |
Stericycle, Inc. Reports Results For the First Quarter 2020 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the First Quarter 2020 BANNOCKBURN, Ill., May 7, 2020 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2020. Revenues for the quarter were $785.0 million, a decrease of 5.4% from $830.1 million in the first quarter of last year. |
|
| May 7, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle, |
|
| April 9, 2020 |
2020 Proxy Statement We protect what matters.2020 PROXY STATEMENT Our Company At A Glance Stericycle is a global business-to-business services company. We provide an array of highly specialized solutions serving healthcare organizations and commercial businesses of every size. Since our founding in 1989, we have grown from a small start-up in medical waste management into a leader across a range o |
|
| April 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Defin |
|
| April 9, 2020 |
SRCL / Stericycle, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| April 6, 2020 |
Stericycle Completes Divestiture of its Domestic Environmental Solutions Business Exhibit 99.1 Contact: Stericycle Investor Relations 847-607-2012 Stericycle Completes Divestiture of its Domestic Environmental Solutions Business BANNOCKBURN, Ill., April 6, 2020 – Stericycle, Inc. (Nasdaq: SRCL) today announced that it has completed the previously reported divestiture of the Domestic Environmental Solutions business, excluding the healthcare customer and unused consumer pharmace |
|
| April 6, 2020 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 30, 2020 |
EX-10.1 2 srcl-ex10168.htm EX-10.1 Exhibit 10.1 [Execution] 9986/48254-001 CURRENT/115004776v10 US-DOCS\114747541.7 Stericycle, Inc. 2355 Waukegan Road Bannockburn, IL 60015 March 26, 2020 VIA EMAIL Roy J. Katzovicz Chief Executive Officer Saddle Point Management, L.P. 555 West 57th Street, STE 1326 New York, NY 10019 Re: Cooperation Agreement Dear Roy, On behalf of the board of directors (the “Bo |
|
| March 30, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):March 26, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 30, 2020 |
Exhibit 99.1 Stericycle Nominates New Candidates for Election to Board of Directors Nominees Include James J. Martell and James L. Welch Company Announces Agreement with Saddle Point Management, L.P. BANNOCKBURN, Ill., March 27, 2020 (Globe Newswire) - Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle” or the “Company”) today announced that its Board of Directors has agreed to nominate James J. Martell |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan Exhibit 10.21 Participants Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstatutory stock o |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to U.K. Non-Executive) Exhibit 10.39 UK Participants NOT Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant, with the relevant company employing the Participant being Employe |
|
| February 28, 2020 |
Description of the Company's Common Stock Exhibit 4.5 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The common stock of Stericycle, Inc. (“we,” “our,” or “us”) is the only class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended. The following is a description of the material terms of our common stock. The description is qualifi |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2011 Plan EX-10.35 9 srcl-ex1035459.htm EX-10.35 Exhibit 10.35 Participants NOT Eligible for Executive Severance and CIC Plan Includes Retirement Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2011 Incentive Stock Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the fo |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to Canada Non-Executive) Exhibit 10.41 Participants NOT Eligible for Executive Severance and CIC Plan Canada Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstatut |
|
| February 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle, Inc. (Exact name |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to Chile Non-Executive) Exhibit 10.44 Chile Participants NOT Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstatuto |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2011 Plan Exhibit 10.19 Participants Eligible for Executive Severance and CIC Plan Includes Retirement Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2011 Incentive Stock Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nons |
|
| February 28, 2020 |
Form on Agreement of Stock Option Grant under 2017 Plan Exhibit 10.26 Participants NOT Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstatutory sto |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to Spain) Exhibit 10.37 Spain Participants NOT Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstatuto |
|
| February 28, 2020 |
Exhibit 10.43 Participants NOT Eligible for Executive Severance and CIC Plan—Business Transformation 2019 Performance-Based Restricted Stock Unit Award (Stericycle, Inc. 2017 Long-Term Incentive Plan) Participant: PSU Grant Date: Number of PSU shares: Performance Period: January 1, 2019 through December 31, 2022 Performance Year:Each calendar year during the Performance Period THIS PERFORMANCE-BAS |
|
| February 28, 2020 |
Exhibit 21 Subsidiaries of Registrant US Subsidiaries* 1. BFI Medical Waste, Inc. (Delaware) 2. Boost GP Acquisition HoldCo, LLC (Delaware) 3. Shred-it US HoldCo, Inc. (Delaware) 4. Stericycle Communication Solutions, Inc. (Delaware) 5. Stericycle Environmental Solutions, Inc. (Delaware) (f/k/a PSC Holdings, Inc.) 6. Stericycle International, LLC (Delaware) 7. Stericycle Management, LLC (Delaware) |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2014 Plan EX-10.20 4 srcl-ex1020464.htm EX-10.20 Exhibit 10.20 Participants Eligible for Executive Severance and CIC Plan Includes Retirement Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2014 Incentive Stock Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the follow |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to Ireland Non-Executive) Exhibit 10.40 Ireland Participants NOT Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstatu |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to Singapore Non-Executive) Exhibit 10.42 Singapore - Participants NOT Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nons |
|
| February 28, 2020 |
Form of Agreement for Performance-Based Restricted Stock Unit Award under 2017 Plan Exhibit 10.23 Participants Eligible for Executive Severance and CIC Plan Performance-Based Restricted Stock Unit Award (Stericycle, Inc. 2017 Long-Term Incentive Plan) Participant: %%FIRSTNAME%-% %%LASTNAME%-% PSU Grant Date: %%OPTIONDATE,'Month DD, YYYY'%-% Number of PSU Shares: %%TOTALSHARESGRANTED,'999,999,999'%-% Performance Period: January 1, 2019 through December 31, 2022 Performance Year: E |
|
| February 28, 2020 |
Executive Severance and Change in Control Plan (as amended) EX-10.33 8 srcl-ex10331061.htm EX-10.33 Exhibit 10.33 STERICYCLE, INC. EXECUTIVE SEVERANCE AND CHANGE IN CONTROL PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2020 TABLE OF CONTENTS Page Article I Statement of Purpose and Effective Date 1 1.01 Purpose1 1.02 Effective Date1 Article II Definitions 1 2.01 “Accrued Annual Incentive”1 2.02 “Accrued Base Salary”1 2.03 “Accrued Obligations”1 2.04 “Af |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2014 Plan Exhibit 10.36 Participants NOT Eligible for Executive Severance and CIC Plan Includes Retirement Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2014 Incentive Stock Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a |
|
| February 28, 2020 |
Form of Agreement for Stock Option Grant under 2017 Plan (related to U.K. Executive) Exhibit 10.38 UK Participants Eligible for Executive Severance and CIC Plan Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant, with the relevant company employing the Participant being Employer), |
|
| February 27, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 27, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 27, 2020 |
Exhibit 10.1 EXECUTION VERSION STERICYCLE, INC. FIFTH AMENDMENT This FIFTH AMENDMENT, dated as of February 25, 2020 (this “Amendment”), is entered into by and among STERICYCLE, INC., a Delaware corporation (the “Company”), the Subsidiaries of the Company signatory hereto (collectively, the “Subsidiary Loan Parties”), the Lenders (as defined below) signatory hereto, and BANK OF AMERICA, N.A., as ad |
|
| February 27, 2020 |
Stericycle, Inc. Reports Results For the Fourth Quarter 2019, Provides 2020 Guidance EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Fourth Quarter 2019, Provides 2020 Guidance BANNOCKBURN, Ill., February 27, 2020 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2019 and provided guidance for the year ending December 31, 2020. Revenues for the quarter |
|
| February 18, 2020 |
SRCL / Stericycle, Inc. / ALLIANCEBERNSTEIN L.P. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Stericycle Inc (Name of Issuer) Common Stock (Title of Class of Securities) 858912108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 12, 2020 |
SRCL / Stericycle, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Stericycle Inc Title of Class of Securities: Common Stock CUSIP Number: 858912108 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule |
|
| February 7, 2020 |
Exhibit 2.1 EXECUTION VERSION STOCK PURCHASE AGREEMENT dated as of February 6, 2020 by and between STERICYCLE, INC., HARSCO CORPORATION and CEI HOLDING, LLC TABLE OF CONTENTS Article I definitions Section 1.01 Definitions1 Section 1.02 Cross References16 Section 1.03 Other Definitional and Interpretative Provisions18 Article II Purchase and Sale Section 2.01 Purchase and Sale of the Purchased Shar |
|
| February 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 7, 2020 |
Exhibit 99.1 Stericycle Announces Agreement to Sell Environmental Solutions Business to Harsco Transaction Furthers Progress on Portfolio Rationalization Efforts BANNOCKBURN, Ill., February 7, 2020 – Stericycle, Inc. (Nasdaq: SRCL) today announced that it has entered into a definitive agreement to sell its Domestic Environmental Solutions business, excluding the healthcare customer and unused cons |
|
| January 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2020 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 31, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| October 31, 2019 |
Stericycle, Inc. Reports Results For the Third Quarter 2019 EX-99.1 2 srcl-ex9916.htm EX-99.1 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Third Quarter 2019 BANNOCKBURN, Ill., October 31, 2019 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the third quarter ended September 30, 2019. Revenues for the quarter were $833.1 million, a decrease of 2.6% from $854.9 |
|
| October 31, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericyc |
|
| October 2, 2019 |
Costs Associated with Exit or Disposal Activities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File |
|
| August 1, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 1, 2019 |
Stericycle, Inc. Reports Results For the Second Quarter 2019 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Stericycle Investor Relations 847-607-2012 Stericycle, Inc. Reports Results For the Second Quarter 2019 LAKE FOREST, Ill., August 1, 2019 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2019 and updated guidance for the full year. Revenues for the quarter were $845.8 million, a decrease of 4.2% from $883.3 |
|
| August 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle, I |
|
| July 3, 2019 |
SRCL / Stericycle, Inc. CORRESP - - July 3, 2019 VIA EDGAR Mr. Ameen Hamady, Division of Corporation Finance Office of Manufacturing and Construction U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Stericycle Inc. Form 10-Q for period ended March 31, 2019 Filed on May 2, 2019 File No. 001-37556 Dear Mr. Hamady: We write in response to your letter of June 17, 2019, and for the convenience of the |
|
| June 14, 2019 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission F |
|
| June 14, 2019 |
EX-10.1 3 d762550dex101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION STERICYCLE, INC. FOURTH AMENDMENT This FOURTH AMENDMENT, dated as of June 14, 2019 (this “Amendment”), is entered into by and among STERICYCLE, INC., a Delaware corporation (the “Company”), the Subsidiaries of the Company signatory hereto (collectively, the “Subsidiary Loan Parties”), the Lenders (as defined below) signatory hereto |
|
| June 14, 2019 |
Stericycle Announces Closing of Sale of $600.0 Million 5.375% Senior Notes Due 2024 EX-99.1 Exhibit 99.1 Stericycle Announces Closing of Sale of $600.0 Million 5.375% Senior Notes Due 2024 LAKE FOREST, IL., June 14, 2019 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) announced today that it has closed its previously announced sale of $600.0 million aggregate principal amount of 5.375% senior notes due July 2024 (the “Notes”). Stericycle used the net proceeds fr |
|
| June 14, 2019 |
EX-4.1 Exhibit 4.1 INDENTURE Dated as of June 14, 2019 Between STERICYCLE, INC., THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO And U.S. BANK NATIONAL ASSOCIATION, as Trustee 5.375% SENIOR NOTES DUE 2024 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 26 Section 1.03. [Reserved] 26 Section 1.04. Rules of Co |
|
| June 7, 2019 |
Stericycle Announces Pricing of $600.0 Million Senior Notes Offering EX-99.1 Exhibit 99.1 Stericycle Announces Pricing of $600.0 Million Senior Notes Offering LAKE FOREST, IL., June 7, 2019 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) announced today that it has priced an offering of $600.0 million aggregate principal amount of 5.375% senior notes due July 2024 (the “Notes”). The notes were priced at par and will be senior unsecured obligations |
|
| June 7, 2019 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 4, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 4, 2019 |
Stericycle Announces Proposed Offering of $550.0 Million in Senior Notes EX-99.1 Exhibit 99.1 Stericycle Announces Proposed Offering of $550.0 Million in Senior Notes LAKE FOREST, ILL., June 4, 2019 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) announced today that it intends to commence an offering of $550.0 million aggregate principal amount of senior notes due 2024 (the “Notes”), subject to market and other conditions. The Notes will be senior un |
|
| May 23, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 2, 2019 |
Exhibit 99.1 Investor Relations 847-607-2012 Stericycle Announces CFO and New Senior Leaders Janet Zelenka to become CFO Dominic Culotta and Cory White join the Executive Team LAKE FOREST, Ill., May 2, 2019 – Stericycle, Inc. (Nasdaq: SRCL) today announced that Janet H. Zelenka has been appointed Executive Vice President and Chief Financial Officer, effective June 1, 2019. Ms. Zelenka brings deep |
|
| May 2, 2019 |
Stericycle, Inc. Reports Results for the First Quarter 2019 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Investor Relations 847-607-2012 Stericycle, Inc. Reports Results for the First Quarter 2019 LAKE FOREST, Ill., May 2, 2019 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2019 and reaffirmed 2019 guidance. Revenues for the quarter were $830.1 million, a decrease of 7.3% from $895.0 million in the first qua |
|
| May 2, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 srcl-8k20190502.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorpora |
|
| May 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37556 Stericycle, Inc. (Exact |
|
| April 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) ( |
|
| April 17, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation |
|
| April 10, 2019 |
SRCL / Stericycle, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| April 10, 2019 |
SRCL / Stericycle, Inc. DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 25, 2019 |
Financial Statements and Exhibits, 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| March 25, 2019 |
Exhibit 99.1 FOR FURTHER INFORMATION CONTACT: Investor Relations 847-607-2012 Stericycle Appoints Joel Hackney, Jr. and Stephen C. Hooley to Board of Directors LAKE FOREST, Ill., March 25, 2019 - Stericycle, Inc. (Nasdaq: SRCL) today announced the appointment of J. Joel Hackney, Jr. and Stephen C. Hooley to the Stericycle Board of Directors. “Stericycle has been proactively refreshing its Board of |
|
| February 28, 2019 |
Exhibit 99.1 Stericycle Announces Senior Leadership Transitions Cindy J. Miller to become President and CEO; Charles A. Alutto to retire as CEO Daniel V. Ginnetti, CFO, to become EVP of International following appointment of a successor Mark C. Miller and Thomas D. Brown to retire from the Board of Directors LAKE FOREST, Ill., February 28, 2019 – Stericycle, Inc. (Nasdaq: SRCL) today announced tha |
|
| February 28, 2019 |
Exhibit 10.1 CONFIDENTIAL TRANSITION AGREEMENT AND GENERAL RELEASE This Confidential Transition Agreement and General Release (“Agreement”) is entered into by and between Stericycle, Inc. (the “Company” or “Stericycle”) and Charles Alutto (“Employee”). WHEREAS, Employee previously was selected to participate in the Company’s Executive Severance and Change in Control Plan with an effective date of |
|
| February 28, 2019 |
Financial Statements and Exhibits, 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 28, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2019 Stericycle, Inc. (Exact name of registrant as specified in its charter) Delaware 1-37556 36-3640402 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 28, 2019 |
Stericycle, Inc. Reports Results for the Fourth Quarter 2018 EXHIBIT 99.1 FOR FURTHER INFORMATION CONTACT: Investor Relations 847-607-2012 Stericycle, Inc. Reports Results for the Fourth Quarter 2018 LAKE FOREST, Ill., February 28, 2019 - Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter 2018. FOURTH QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR: • Revenues were $852.7 million, a decrease of 4.0%; organic revenues decreased 1.1%, ref |
|
| February 28, 2019 |
Exhibit 21 Subsidiaries of Registrant US Subsidiaries* 1. BFI Medical Waste, Inc. (Delaware) 2. Boost GP Acquisition HoldCo, LLC (Delaware) 3. Shred-it US HoldCo, Inc. (Delaware) 4. Stericycle Communication Solutions, Inc. (Delaware) 5. Stericycle Environmental Solutions, Inc. (Delaware) (f/k/a PSC Holdings, Inc.) 6. Stericycle International, LLC (Delaware) 7. Stericycle Management, LLC (Delaware) |
|
| February 28, 2019 |
Exhibit 10.46 Participants Eligible for Executive Severance and CIC Plan Draft 1-2-19 Stock Option Award Agreement (Nonstatutory Stock Option Under Stericycle, Inc. 2017 Long-Term Incentive Plan) Stericycle, Inc., a Delaware corporation (the Company), grants to the following employee of the Company or one of its Subsidiaries (Participant), as of the following grant date (the Grant Date), a nonstat |
